Table 2 Health and economic outcomes of HPV vaccination, discounted
From: Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan
Outcome | No vaccination | HPV vaccination |
|---|---|---|
Cost, US$ | 129 | 453 |
Incremental cost, US$ | Â | 324 |
Life expectancy, years | 28.830 | 28.844 |
Incremental life expectancy, days | Â | 4.9 |
Quality-adjusted life expectancy, years | 28.816 | 28.840 |
Incremental quality-adjusted life expectancy, days | Â | 8.7 |
Incremental cost-effectiveness ratio | Â | Â |
   US$/life year |  | 23 939 |
   US$/quality-adjusted life year |  | 13 674 |